ATMPs prepared under hospital exemption: European Blood Alliance position paper

Affiliations

¹ European Blood Alliance Brussels Belgium.
² Scottish National Blood Transfusion Service, The Jack Copland Centre Edinburgh UK.
³ Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland Vienna Austria.
⁴ Department of Transfusion Medicine Paracelsus Medical University Hospital Salzburg Austria.
⁵ Finnish Red Cross Blood Service Vantaa Finland.
⁶ Slovenian Institute for Transfusion Medicine Ljubljana Slovenia.
⁷ National Blood Transfusion Service Pietà Malta.
⁸ Karolinska University Hospital Stockholm Sweden.
⁹ Laboratory Medicine and Pathology, Department of Immunology and Transfusion Medicine Haukeland University Hospital Bergen Norway.
¹⁰ Welsh Blood Service Llantrisant UK.
¹¹ NHS Blood and Transplant Bristol UK.
¹² French Blood Establishment (EFS) La Plaine Saint-Denis France.
¹³ Portuguese Institute of Blood and Transplantation Lisboa Portugal.
¹⁴ Laboratory for Cell Therapy and Amsterdam UMC, Department of Research, Sanquin Blood Supply Foundation University of Amsterdam Amsterdam The Netherlands.

Editorial

Dragoslav Domanović et al. Hemasphere. 2025.

. 2025 Sep 23;9(9):e70215.

doi: 10.1002/hem3.70215. eCollection 2025 Sep.

¹ European Blood Alliance Brussels Belgium.
² Scottish National Blood Transfusion Service, The Jack Copland Centre Edinburgh UK.
³ Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland Vienna Austria.
⁴ Department of Transfusion Medicine Paracelsus Medical University Hospital Salzburg Austria.
⁵ Finnish Red Cross Blood Service Vantaa Finland.
⁶ Slovenian Institute for Transfusion Medicine Ljubljana Slovenia.
⁷ National Blood Transfusion Service Pietà Malta.
⁸ Karolinska University Hospital Stockholm Sweden.
⁹ Laboratory Medicine and Pathology, Department of Immunology and Transfusion Medicine Haukeland University Hospital Bergen Norway.
¹⁰ Welsh Blood Service Llantrisant UK.
¹¹ NHS Blood and Transplant Bristol UK.
¹² French Blood Establishment (EFS) La Plaine Saint-Denis France.
¹³ Portuguese Institute of Blood and Transplantation Lisboa Portugal.
¹⁴ Laboratory for Cell Therapy and Amsterdam UMC, Department of Research, Sanquin Blood Supply Foundation University of Amsterdam Amsterdam The Netherlands.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. European Commission . Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on Advanced Therapy Medicinal Products and Amending Directive 2001/83/EC and Regulation (EC) No 726/2004.
1. CAT quarterly highlights and approved ATMPs. European Medicines Agency. May 2025. Accessed July 10, 2025. https://www.ema.europa.eu/en/documents/committee-report/cat-quarterly-hi...
1. Hills A, Awigena‐Cook J, Genenz K, et al. An assessment of the hospital exemption landscape across European Member States: regulatory frameworks, use and impact. Cytotherapy. 2020;22(12):772‐779.e1. 10.1016/j.jcyt.2020.08.011 - DOI - PubMed
1. European Commission's 2023 proposal to revise the Medicinal Products Directive. European Commission. 2023. Accessed July 4, 2025. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:52023PC0192
1. Joint Position Paper on the Hospital Exemption Scheme for ATMPs. EFPIA. Accessed July 4, 2025. https://efpia.eu/news-events/the-efpia-view/efpia-news/joint-position-pa...